MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2014 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
103 M |
Marktkapitalisierung |
$ 4.46 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
BioNano Genomics
BNGO
|
$ 1.23 | 4.24 % | $ 6.7 M | Nasdaq Capital Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 1.52 | 0.32 % | $ 3.49 M | Nasdaq Capital Market | USA |
 |
Brainsway Ltd.
BWAY
|
$ 15.17 | 3.48 % | $ 515 M | Nasdaq Global Select Market |  Israel |
 |
Celcuity
CELC
|
$ 93.65 | 0.44 % | $ 4.38 B | Nasdaq Global Select Market | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 290.0 | 3.87 % | $ 14.4 B | NYSE,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 1.1 | 1.98 % | $ 1.46 M | Nasdaq Capital Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
$ 241.76 | 2.33 % | $ 26.8 B | NYSE,SPB | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
DarioHealth Corp.
DRIO
|
$ 7.16 | 5.43 % | $ 28.5 M | Nasdaq Capital Market | Israel |
 |
DexCom
DXCM
|
$ 89.88 | 0.31 % | $ 35.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
Interpace Biosciences
IDXG
|
$ 1.57 | 2.41 % | $ 6.95 M | Nasdaq Global Select Market | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
ICON Public Limited Company
ICLR
|
$ 172.49 | 3.26 % | $ 13.5 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IQVIA Holdings
IQV
|
$ 249.28 | 3.85 % | $ 42.9 B | NYSE,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.71 | 8.16 % | $ 120 K | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market |  Schweiz |
 |
Mettler-Toledo International
MTD
|
$ 1 425.09 | 1.82 % | $ 29.4 B | NYSE,SPB | Schweiz |
 |
NeoGenomics
NEO
|
$ 16.66 | 4.75 % | $ 2.13 B | Nasdaq Global Select Market,SPB | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |
 |
National Research Corporation
NRC
|
$ 21.98 | 0.09 % | $ 492 M | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 3.19 | 11.15 % | $ 295 M | Nasdaq Global Select Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 4.52 | 0.22 % | $ 3.56 M | Nasdaq Global Select Market | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |
 |
Natera
NTRA
|
$ 325.07 | 4.29 % | $ 44.4 B | Nasdaq Global Select Market,SPB | USA |